GINA ALOISIO to Respiratory Syncytial Virus Infections
This is a "connection" page, showing publications GINA ALOISIO has written about Respiratory Syncytial Virus Infections.
Connection Strength
1.313
-
Infant-derived human nasal organoids exhibit relatively increased susceptibility, epithelial responses, and cytotoxicity during RSV infection. J Infect. 2024 Dec; 89(6):106305.
Score: 0.683
-
Single cell sequencing analysis of respiratory syncytial virus-infected pediatric and adult human nose organoids reveals age differences, proliferative diversity and identifies novel cellular tropism. J Infect. 2025 Oct; 91(4):106617.
Score: 0.182
-
Characterizing respiratory syncytial virus (RSV) infections before and during the COVID-19 pandemic. Am J Emerg Med. 2025 Jan; 87:108-112.
Score: 0.172
-
Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection. J Virol. 2022 04 13; 96(7):e0190421.
Score: 0.143
-
The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio. 2021 02 22; 13(1):e0351121.
Score: 0.133